30 results about "Fructosamine" patented technology

The invention relates to a process flow to produce a sesquiterpene inside a golden fungus fermentation liquid and the virtue of the sesquiterpene produced by the golden fungus to reduce the blood sugar, belonging to the biological fermentation and medicine field. The process flow is characterized in that the process flow applicant finds the fermentation liquid and the sesquiterpene produced by the production process are applied on a high blood sugar mouse through an oral administration route, the mouse significantly reduces the blood sugar and the fructosamine, which approves that the golden fungus fermentation liquid and the sesquiterpene are possessed of preparing a health care drink and medicine to reduce the blood sugar; the fermentation liquid color is orange to yellow-brown; the inhibitive rate to the ex vivo non-enzymic glycosylation is up to 72% to 90% with the fermentation liquid and 5mg / ml sesquiterpene. The process flow to produce a sesquiterpene inside a golden fungus fermentation liquid and the virtue of the sesquiterpene produced by the golden fungus to reduce the blood sugar has the advantages of not only creating a fire-new channel to further develop the golden fungus but also providing an ideal Chinese herbal medicine to reduce blood sugar.

The invention relates to a tumor specific growth factor detection kit. The kit comprises an R1 reagent, an R2 reagent and a standard substance solution, the R1 reagent comprises phosphate, disodium ethylene diamine tetraacetate, Kathon and 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid, and the solvent of the R1 reagent is purified water; the R2 reagent comprises a developer, Kathon, sodium citrate and glycerin, and the solvent of the R2 reagent is purified water; and the standard substance solution comprises a solution A and a solution B, the solution A is purified water, and the solution B is a sialic acid, homocysteine and fructosamine mixed solution. The kit has the advantages of substantial simplification of detection steps, cost saving, simple practical operation, no need of a precious device, and extremely easy popularization.

The invention discloses a 6-fructosamine-4-arylamidoquinazoline derivative with the structural formula of formula I or a pharmaceutically acceptable salt thereof, and relates to a preparation method and a purpose of above compounds. According to the invention, fructose is connected to a 4-arylamidoquinazoline derivative, so the water solubility of the compounds and the selectivity of the compounds to tumor cells are improved.

The invention discloses a fructosamine determination kit, which includes R1 reagent and R2 reagent, wherein the pH of the R1 reagent is 10.0-10.8, including: 200-500mmol / L alkaline buffer solution, 1-10g / L metal salt, 0.5- 2g / L mixture of Emulgen A90 and Emulgen B66 in equal volume ratio, 0.5-2g / L preservative; R2 reagent pH 4.0-5.0, including: 5mmol / L-25mmol / L acidic buffer, 0.5-2g / L isopropylamine phenyl sulfonate; 1~5g / L NBT and 0.5~2g / L preservative. The present invention specially selects the equal volume ratio mixture of Emulgen A90 and Emulgen B66 in the R1 reagent, cooperates with the strong alkaline environment to effectively remove the interfering substances in the serum sample; and in the R2 reagent, the acidic environment and isopropylamine alkyl The benzenesulfonate is used in conjunction with it, and the concentration of the buffer is appropriately reduced to enhance the solubility of NBT and the stability of the reagent, and at the same time improve the precision and linear range of the reagent, thus obtaining a significantly enhanced anti-interference ability and stability , and the linearity and precision of the reagent are also more excellent fructosamine determination kit.

A method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from fructosamine and factor VII.